[go: up one dir, main page]

NO20014256D0 - Fremstilling av immunstimulerende forbindelse - Google Patents

Fremstilling av immunstimulerende forbindelse

Info

Publication number
NO20014256D0
NO20014256D0 NO20014256A NO20014256A NO20014256D0 NO 20014256 D0 NO20014256 D0 NO 20014256D0 NO 20014256 A NO20014256 A NO 20014256A NO 20014256 A NO20014256 A NO 20014256A NO 20014256 D0 NO20014256 D0 NO 20014256D0
Authority
NO
Norway
Prior art keywords
preparation
immunostimulatory compound
immunostimulatory
compound
Prior art date
Application number
NO20014256A
Other languages
English (en)
Inventor
Bjoern Kristiansen
David Waddell
Original Assignee
Bjoern Kristiansen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bjoern Kristiansen filed Critical Bjoern Kristiansen
Priority to NO20014256A priority Critical patent/NO20014256D0/no
Publication of NO20014256D0 publication Critical patent/NO20014256D0/no
Priority to US10/488,427 priority patent/US20050163800A1/en
Priority to PCT/IB2002/003557 priority patent/WO2003020944A2/en
Priority to EP02762662.1A priority patent/EP1451336B1/en
Priority to AU2002328099A priority patent/AU2002328099A1/en
Priority to US11/305,136 priority patent/US20060094689A1/en
Priority to US12/896,726 priority patent/US8758768B2/en
Priority to US14/162,272 priority patent/US9249438B2/en
Priority to US15/008,891 priority patent/US10471135B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20014256A 2001-09-03 2001-09-03 Fremstilling av immunstimulerende forbindelse NO20014256D0 (no)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NO20014256A NO20014256D0 (no) 2001-09-03 2001-09-03 Fremstilling av immunstimulerende forbindelse
US10/488,427 US20050163800A1 (en) 2001-09-03 2002-09-03 Production of fungal extracellular immune stimulating compounds
PCT/IB2002/003557 WO2003020944A2 (en) 2001-09-03 2002-09-03 Production of fungal extracellular immune stimulating compounds
EP02762662.1A EP1451336B1 (en) 2001-09-03 2002-09-03 Production of fungal extracellular immune stimulating compounds
AU2002328099A AU2002328099A1 (en) 2001-09-03 2002-09-03 Production of fungal extracellular immune stimulating compounds
US11/305,136 US20060094689A1 (en) 2001-09-03 2005-12-19 Production of fungal extracellular immune stimulating compounds
US12/896,726 US8758768B2 (en) 2001-09-03 2010-10-01 Process for production of fungal extracellular immune stimulating compounds
US14/162,272 US9249438B2 (en) 2001-09-03 2014-01-23 Production of fungal extracellular immune stimulating compounds
US15/008,891 US10471135B2 (en) 2001-09-03 2016-01-28 Production of fungal extracellular immune stimulating compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20014256A NO20014256D0 (no) 2001-09-03 2001-09-03 Fremstilling av immunstimulerende forbindelse

Publications (1)

Publication Number Publication Date
NO20014256D0 true NO20014256D0 (no) 2001-09-03

Family

ID=19912789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014256A NO20014256D0 (no) 2001-09-03 2001-09-03 Fremstilling av immunstimulerende forbindelse

Country Status (5)

Country Link
US (5) US20050163800A1 (no)
EP (1) EP1451336B1 (no)
AU (1) AU2002328099A1 (no)
NO (1) NO20014256D0 (no)
WO (1) WO2003020944A2 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (no) 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
US8722056B2 (en) * 2003-10-03 2014-05-13 Tcm Biotech International Corp. Methods for making and compositions comprising fermentation products of cordyceps sinensis
NO20044581L (no) * 2004-01-12 2005-07-13 Geir Hetland Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier
EP1774012A2 (en) * 2004-07-16 2007-04-18 Medimush A/S Immune modulating compounds from fungi
US7514085B2 (en) * 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
CN1296389C (zh) * 2004-09-14 2007-01-24 武汉大学 一种具有抗肿瘤活性的三螺旋香菇多糖及其制法和用途
EP1709969A1 (en) * 2005-04-07 2006-10-11 Praktijkonderzoek Plant en Omgeving B.V. Health promoting dairy and food products containing mushroom glucan produced through fermentation of Grifola frondosa
EP1885866A1 (en) * 2005-05-13 2008-02-13 Medimush A/S Feed or food products comprising fungal material
WO2006133708A1 (en) * 2005-06-15 2006-12-21 Medimush A/S Bioactive agents produced by submerged cultivation of a basidiomycete cell
EP1896600A2 (en) * 2005-06-15 2008-03-12 Medimush A/S Anti-cancer combination treatment and kit-of-part
CN100500860C (zh) * 2006-07-21 2009-06-17 华南理工大学 一种高活性金针菇多糖-肽-Fe2+鳌合物及其制备方法
US20080187574A1 (en) * 2007-02-05 2008-08-07 Holliday John C Mycellated grain and other myceliated agricultural materials to be used as animal food supplement
RU2475529C2 (ru) * 2011-03-14 2013-02-20 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") ИНГИБИТОР РЕПРОДУКЦИИ ВИРУСА ГРИППА А НА ОСНОВЕ ЭКСТРАКТА БАЗИДИАЛЬНОГО ГРИБА Phallus impudicus
WO2014122627A1 (en) 2013-02-11 2014-08-14 Glycanova As Basidiomycete-derived cream for treatment of skin diseases
WO2019148418A1 (zh) * 2018-02-01 2019-08-08 江南大学 一种添加苯丙氨酸提高食药用真菌胞外多糖产量的方法
CN110713550B (zh) * 2018-07-12 2022-03-15 浙江省亚热带作物研究所 一种利用虫草培养物制备具有抑菌活性精多糖的方法
CN113832045A (zh) * 2020-06-23 2021-12-24 点斗基因科技(南京)有限公司 多种植物提取物与多种益生菌分时发酵培养方法
WO2021260198A1 (en) * 2020-06-26 2021-12-30 Nutreco Ip Assets B.V. Agaricus blazei fermented grains against lawsonia intracellularis infection
CN112023038B (zh) * 2020-09-13 2023-05-26 天津市泌尿外科研究所 一种复合免疫增强剂
CN115120618B (zh) * 2021-03-23 2024-01-26 安徽盛美诺生物技术有限公司 具有改善免疫应答作用的软骨提取物、其制备方法及其用途
CN116064699A (zh) * 2023-01-19 2023-05-05 安徽师范大学 平菇胞外多糖在制备解藻毒素毒性的药物中的应用
AU2023274205B1 (en) * 2023-12-01 2025-02-27 Vetanda Korea Limited An improved method of preparing extracts and extracts prepared by the method

Family Cites Families (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987166A (en) * 1970-05-13 1976-10-19 Kaken Kagaku Kabushiki Kaisha Treatment of tumors with glucan compositions in mice and rats
US3943247A (en) * 1972-05-22 1976-03-09 Kaken Kagaku Kabushiki Kaisha Treatment of bacterial infections with glucan compositions
JPS5616765B2 (no) * 1975-02-05 1981-04-18
US4174388A (en) * 1977-02-14 1979-11-13 Merck & Co., Inc. Method for preparing hepatitis B immune globulin
JPS54148702A (en) * 1978-05-12 1979-11-21 Kirin Brewery Kss22b
JPS5653101A (en) 1979-09-21 1981-05-12 Kirin Brewery Co Ltd Polysaccharide ks-2-d and its preparation
US4454289A (en) * 1981-03-06 1984-06-12 Takara Shuzo Co., Ltd. Polysaccharides having anticarcinogenic activity and method for producing same
JPS58118519A (ja) * 1981-12-29 1983-07-14 Noda Shiyokukin Kogyo Kk 抗がん剤
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
SU1244179A1 (ru) 1983-12-29 1986-07-15 Московский ордена Ленина и ордена Трудового Красного Знамени химико-технологический институт им.Д.И.Менделеева Способ глубинного выращивани гриба @ @ ( @ ) @ @ -1300
JPH0757761B2 (ja) * 1984-03-08 1995-06-21 株式会社林原生物化学研究所 β−グルカンとその製造方法及び用途
EP0292601A1 (en) * 1987-05-14 1988-11-30 Noda Shokukin Kogyo Co., Ltd. Anti aids drug extracted from lentinus edodes
JPS63296662A (ja) 1987-05-28 1988-12-02 Toru Arai キノコ菌飲食物
EP0298706B1 (en) 1987-07-07 1994-09-07 Ajinomoto Co., Inc. Use of glycans in the manufacturing of anti-viral medicaments.
JP2676375B2 (ja) 1987-08-05 1997-11-12 イハラケミカル工業株式会社 きのこ類の栽培方法
FR2631829B1 (fr) * 1988-05-30 1992-04-03 Pasteur Institut Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
JP2947560B2 (ja) 1988-11-14 1999-09-13 野田食菌工業株式会社 エイズ治療剤およびその製造方法
JPH037236A (ja) 1989-02-10 1991-01-14 Nippon Chem Res Kk ヘルペスウイルスの吸着阻害剤
US5283239A (en) * 1989-02-10 1994-02-01 Jcr Pharmaceuticals Co. Ltd. Inhibitor of herpesvirus absorption
US5032401A (en) * 1989-06-15 1991-07-16 Alpha Beta Technology Glucan drug delivery system and adjuvant
EP0491829B1 (en) * 1989-09-08 1997-06-04 Alpha Beta Technology, Inc. Composition for immune system activation
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
AU650626B2 (en) * 1989-09-08 1994-06-30 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US6143731A (en) * 1989-10-20 2000-11-07 The Collaborative Group, Ltd. Glucan dietary additives
US6020324A (en) * 1989-10-20 2000-02-01 The Collaborative Group, Ltd. Glucan dietary additives
ES2099099T3 (es) 1989-11-03 1997-05-16 Alexander S Sun Tratamiento herbaceo de enfermedades malignas.
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
JPH0665649B2 (ja) * 1991-02-01 1994-08-24 台糖株式会社 甲殻類の生体防御能増強剤、感染症予防ワクチン及び飼料
JP3522772B2 (ja) * 1991-05-21 2004-04-26 台糖株式会社 ワクチンの免疫効果増強剤
CN1032428C (zh) 1992-08-15 1996-07-31 樊菊芬 香菇多糖或香菇菌多糖提取新工艺
US5519009A (en) * 1993-10-01 1996-05-21 Donzis; Byron A. Solubilized yeast glucan
JP3017630B2 (ja) 1993-12-17 2000-03-13 長岡 均 Ｈｉｖ型ウイルス活性阻害剤
US5554746A (en) * 1994-05-16 1996-09-10 Isis Pharmaceuticals, Inc. Lactam nucleic acids
US6110892A (en) * 1994-06-20 2000-08-29 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5622940A (en) * 1994-07-14 1997-04-22 Alpha-Beta Technology Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan
JP3404142B2 (ja) 1994-09-06 2003-05-06 株式会社日立製作所 用紙姿勢制御装置
US5934012A (en) 1994-11-23 1999-08-10 Hps Biotechnologies, Inc. Process for production of mushroom inoculum
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
JP3651697B2 (ja) * 1995-03-24 2005-05-25 株式会社アミノアップ化学 新規多糖体物質
US6117850A (en) * 1995-08-28 2000-09-12 The Collaborative Group, Ltd. Mobilization of peripheral blood precursor cells by β(1,3)-glucan
TW358121B (en) * 1995-12-25 1999-05-11 Hitoshi Nagaoka Method for extracting useful substance from culture medium containing mycelium
US6084092A (en) * 1997-01-31 2000-07-04 The Collaborative Group, Ltd. β(1-3)-glucan diagnostic assays
US6090938A (en) * 1996-05-01 2000-07-18 Collaborative Group, Ltd. Activation of signal transduction by underivatized, aqueous soluble . .beta(1-3)-Glucan
US6110692A (en) * 1996-05-01 2000-08-29 The Collaborative Group, Ltd. Receptor for underivatized aqueous soluble β(1-3)-glucan
US5822940A (en) * 1996-07-17 1998-10-20 Carlin; Steven Composite wall panel
US5744187A (en) * 1996-12-16 1998-04-28 Gaynor; Mitchel L. Nutritional powder composition
US6413715B2 (en) * 1997-01-31 2002-07-02 The Collaborative Group β(1-3)-glucan diagnostic assays
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
US6440448B1 (en) * 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US5997875A (en) 1998-03-27 1999-12-07 Zhou; James H. Herbal composition and treatment methods
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6369216B1 (en) * 1998-09-25 2002-04-09 Biopolymer Engineering Pharmaceutical, Inc. Very high molecular weight β-glucans
AU6261999A (en) * 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
CN1171630C (zh) 1998-11-27 2004-10-20 小林制药株式会社 从香菇菌丝体的提取物来源的lak活性增强剂和含有此提取物的lak活性增强配方
JP2000157203A (ja) 1998-11-27 2000-06-13 Kobayashi Pharmaceut Co Ltd シイタケ菌糸体抽出物を含むγδＴ細胞免疫活性増強剤
WO2000054795A1 (en) 1999-03-15 2000-09-21 The Trustees Of The University Of Pennsylvania Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject
KR20020012183A (ko) 1999-04-23 2002-02-15 유한회사 츠쿠바 바이오시스템 액체배지에서의 담자균의 배양방법
JP4123641B2 (ja) 1999-06-18 2008-07-23 ソニー株式会社 情報処理装置及び方法
US6372462B2 (en) 1999-10-15 2002-04-16 Medmyco Ltd. Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
US6383799B1 (en) * 1999-10-15 2002-05-07 Medmyco Ltd. Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
AU2001225479A1 (en) 2000-01-12 2001-07-24 Life Science Laboratories Co., Ltd. Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs
FR2805465B1 (fr) 2000-02-28 2003-02-21 Medecine Information Formation Nouvelles compositions pharmaceutique ou dietetiques a base de champignons
CN1143866C (zh) 2000-03-20 2004-03-31 武汉迪普生物技术有限公司 一种分离纯化香菇菌多糖的工艺
AU2001252599A1 (en) 2000-04-28 2001-11-12 Orient Cancer Therapy Co., Ltd. Remedies for cancer
EP1155623A1 (en) 2000-05-18 2001-11-21 N.V. Seghers Nutrition Sciences S.A. Growth promoter for animals
JP2002017389A (ja) * 2000-06-30 2002-01-22 Mbiotec Co Ltd 茸細胞外多糖体の製造方法
CN1126547C (zh) 2000-07-19 2003-11-05 南京振中生物工程有限公司 香菇多糖冻干粉针剂及其制备方法
JP4647067B2 (ja) 2000-08-18 2011-03-09 株式会社アミノアップ化学 担子菌培養物由来の組成物及びその用途
JP2002191354A (ja) 2000-10-06 2002-07-09 Kabaiotekku Co Ltd 茸菌糸体の生産方法およびその用途（Ｍｅｔｈｏｄｆｏｒｐｒｏｄｕｃｉｎｇｍｕｓｈｒｏｏｍｍｙｃｅｌｉｕｍａｎｄｕｓｅｓｔｈｅｒｅｏｆ）
CN1236048C (zh) 2000-12-08 2006-01-11 曹文伟 生产食用、药用真菌菌粉和真菌多糖的方法
EP1389466B1 (en) 2001-04-27 2007-02-21 Ajinomoto Co., Inc. A dispersion on the basis of beta-glucan containing superfine particles, a corresponding process of manufacturing and the use of said dispersion
US6582723B2 (en) * 2001-05-03 2003-06-24 Wayne F. Gorsek Cancer immune composition for prevention and treatment of individuals
WO2002098440A1 (en) 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Drugs for diabetes
EP1393734A4 (en) * 2001-06-01 2006-04-12 Ajinomoto Kk DRUG AGAINST DARMER DISEASES
NO20014256D0 (no) 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
EP1314359A1 (en) 2001-11-21 2003-05-28 N.V. Seghers Nutrition Sciences Growth promoter composition for animals
BE1014638A6 (fr) * 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
MXPA04009324A (es) 2002-03-26 2005-01-25 Banyu Pharma Co Ltd Uso de derivado de indolopirrolocarbazol y otro agente anticanceroso en combinacion.
US6702545B2 (en) * 2002-05-01 2004-03-09 Sanford Davis Scholten Venturi fan
KR100470734B1 (ko) 2002-06-19 2005-02-21 주식회사 티지 바이오텍 영지버섯(Ｇａｎｏｄｅｒｍａ ｌｕｃｉｄｕｍ) ＴＧ(ＫＣＴＣ 10241ＢＰ) 균사체 배양액으로부터 고분자물질의 생산방법 및 그 용도
WO2004014320A2 (en) * 2002-08-13 2004-02-19 Biopolymer Engineering, Inc. Methods of using beta glucan as a radioprotective agent
CN1204148C (zh) 2002-08-22 2005-06-01 武汉东保科技开发有限责任公司 香菇菌多糖的分离纯化工艺
US6830310B2 (en) * 2002-10-23 2004-12-14 Hewlett-Packard Development Company, L.P. Detectable markers in cationic polymeric fixers
DE102004010690A1 (de) 2003-02-27 2004-10-21 Ernst-Moritz-Arndt-Universität Greifswald Gesundheitsfördernde Zusammensetzungen aus lipidhaltigen Pilzen und Thiocyanaten
JP4648641B2 (ja) 2003-03-20 2011-03-09 日本製粉株式会社 茸類から脂質を抽出する方法、食品及び化粧料
EP1613206A2 (en) * 2003-04-16 2006-01-11 The University Of Mississippi Immunostimulatory agents in botanicals
EP1625850B1 (en) 2003-05-15 2012-02-29 Japan Science and Technology Agency Immunostimulating agents
CN1220496C (zh) 2003-08-21 2005-09-28 武汉同药药业有限公司 一种用于治疗病毒性肝炎的栓剂及其制备方法
CN1528335A (zh) 2003-09-27 2004-09-15 南昌弘益科技有限公司 香菇菌多糖滴丸及其制备方法
US20050158258A1 (en) * 2004-01-21 2005-07-21 Mary Kay Inc. Methods and compositions for the treatment of skin changes associated with aging and environmental damage
DE102004006825A1 (de) * 2004-02-11 2005-09-01 Maxens Gmbh Verfahren zur Herstellung von aromaaktiven Terpenen
EP1736206B1 (en) * 2004-02-16 2011-10-19 Tadashi Goino Physiologically active composition and process for producing the same
US7484790B2 (en) * 2004-04-16 2009-02-03 Wheatley Donald G Covering structure having automatic coupling system
US20050238654A1 (en) * 2004-04-26 2005-10-27 Yoshinori Takeda Compositions and methods for weight loss
EP1774012A2 (en) 2004-07-16 2007-04-18 Medimush A/S Immune modulating compounds from fungi
JP2006241130A (ja) 2005-03-01 2006-09-14 Buhei Kono 霊芝に含まれる水溶性多糖体の高分子の成分を利用し、コラーゲン繊維の生成及び人体の皮膚のしわ、たるみを改善し、リフティング効果を高める機能。
US7597910B2 (en) * 2005-08-20 2009-10-06 Slgm Medical Research Institute Compositions and methods for treating prostate disorders
CN100453559C (zh) 2005-11-04 2009-01-21 杨勇杰 一种提取香菇多糖的方法
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
ES2628021T3 (es) * 2006-06-15 2017-08-01 Biothera, Inc. Preparaciones de glucano
US20080167268A1 (en) * 2006-09-01 2008-07-10 Jun Yan Particulate beta-glucan compositions for regulating dendritic cells
WO2008027581A1 (en) * 2006-09-01 2008-03-06 University Of Louisville Mcrp antagonists and their uses
US20080160043A1 (en) 2007-07-16 2008-07-03 Kim Moo-Sung Preparation method of beta-glucan from schizophyllum commune and composition for external application comprising the same
US7947283B2 (en) 2007-08-30 2011-05-24 Wyntek Corporation Compositions and methods for treating psoriasis by Ganoderma lucidum (Reishi) polysaccharides
KR101097342B1 (ko) 2010-03-09 2011-12-23 삼성모바일디스플레이주식회사 양자점 유기 전계 발광 소자 및 그 형성방법

Also Published As

Publication number Publication date
US10471135B2 (en) 2019-11-12
WO2003020944A2 (en) 2003-03-13
AU2002328099A1 (en) 2003-03-18
WO2003020944A3 (en) 2004-06-03
EP1451336A2 (en) 2004-09-01
WO2003020944A8 (en) 2005-02-17
EP1451336B1 (en) 2019-05-15
US20140186900A1 (en) 2014-07-03
US9249438B2 (en) 2016-02-02
US20110045026A1 (en) 2011-02-24
US20050163800A1 (en) 2005-07-28
US8758768B2 (en) 2014-06-24
US20060094689A1 (en) 2006-05-04
US20160144008A1 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
NO20014256D0 (no) Fremstilling av immunstimulerende forbindelse
DE60217126D1 (de) Herstellung von aminopyrimidinverbindungen
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20030134L (no) Fremstilling av olefinderivater
PT1438306E (pt) Derivados de uk-20
NO20034127L (no) Forbedring av aromainneholdende bestanddeler
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
DK1414409T3 (da) Stabiliseret oral suspensionsformulering
GB2375022B (en) Configuration of Lan Hosts
DE60210020D1 (de) Herstellung von Polysulfidzusammensetzungen
NO20044916L (no) Preparater av sulfinylacetamid
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
NO20040292L (no) Fremgangsmate for fremstilling av 4-aminodifenylamin
NO20033737D0 (no) PEG-konjugater av IIGT-NK4
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
NO20042667L (no) Fremgangsmate for fremstilling av escitalopram
ITMI20001883A0 (it) Procedimento integrato per la preparazione di epossidi
NO20041968L (no) Anvendelse av cystationin
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20023445D0 (no) Fremgangsmåte for fremstilling av peptider
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20024707L (no) Fremstilling av diacetaler av glyoksal
NO20035146L (no) Granulaere preparater av gaboksadol
NO20043948L (no) Fremstilling av olefiner